Romania
· Delayed Price · Currency is RON Biofarm Statistics
Total Valuation
Biofarm has a market cap or net worth of RON 670.05 million. The enterprise value is 546.21 million.
| Market Cap | 670.05M |
| Enterprise Value | 546.21M |
Important Dates
The last earnings date was Friday, February 28, 2025.
| Earnings Date | Feb 28, 2025 |
| Ex-Dividend Date | Aug 18, 2025 |
Share Statistics
Biofarm has 985.37 million shares outstanding. The number of shares has decreased by -8.77% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 985.37M |
| Shares Change (YoY) | -8.77% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 88.33% |
| Float | 477.14M |
Valuation Ratios
The trailing PE ratio is 9.01.
| PE Ratio | 9.01 |
| Forward PE | n/a |
| PS Ratio | 2.34 |
| PB Ratio | 1.40 |
| P/TBV Ratio | 1.40 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 7.34 |
| EV / Sales | 1.90 |
| EV / EBITDA | 5.71 |
| EV / EBIT | 6.99 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.35
| Current Ratio | 4.35 |
| Quick Ratio | 3.64 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 16.30% and return on invested capital (ROIC) is 10.70%.
| Return on Equity (ROE) | 16.30% |
| Return on Assets (ROA) | 9.31% |
| Return on Invested Capital (ROIC) | 10.70% |
| Return on Capital Employed (ROCE) | 16.30% |
| Revenue Per Employee | 762,690 |
| Profits Per Employee | 197,864 |
| Employee Count | 399 |
| Asset Turnover | 0.55 |
| Inventory Turnover | 0.81 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -16.38% in the last 52 weeks. The beta is 0.31, so Biofarm's price volatility has been lower than the market average.
| Beta (5Y) | 0.31 |
| 52-Week Price Change | -16.38% |
| 50-Day Moving Average | 0.70 |
| 200-Day Moving Average | 0.75 |
| Relative Strength Index (RSI) | 46.24 |
| Average Volume (20 Days) | 19,830 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Biofarm had revenue of RON 286.77 million and earned 74.40 million in profits. Earnings per share was 0.08.
| Revenue | 286.77M |
| Gross Profit | 241.86M |
| Operating Income | 78.12M |
| Pretax Income | 84.53M |
| Net Income | 74.40M |
| EBITDA | 95.73M |
| EBIT | 78.12M |
| Earnings Per Share (EPS) | 0.08 |
Balance Sheet
The company has 123.84 million in cash and n/a in debt, giving a net cash position of 123.84 million or 0.13 per share.
| Cash & Cash Equivalents | 123.84M |
| Total Debt | n/a |
| Net Cash | 123.84M |
| Net Cash Per Share | 0.13 |
| Equity (Book Value) | 478.26M |
| Book Value Per Share | 0.49 |
| Working Capital | 252.89M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 84.34%, with operating and profit margins of 27.24% and 25.94%.
| Gross Margin | 84.34% |
| Operating Margin | 27.24% |
| Pretax Margin | 29.48% |
| Profit Margin | 25.94% |
| EBITDA Margin | 33.38% |
| EBIT Margin | 27.24% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.03, which amounts to a dividend yield of 4.56%.
| Dividend Per Share | 0.03 |
| Dividend Yield | 4.56% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 3 |
| Payout Ratio | n/a |
| Buyback Yield | 8.77% |
| Shareholder Yield | 13.33% |
| Earnings Yield | 11.10% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on April 30, 2008. It was a forward split with a ratio of 1.12001.
| Last Split Date | Apr 30, 2008 |
| Split Type | Forward |
| Split Ratio | 1.12001 |
Scores
Biofarm has an Altman Z-Score of 8.53.
| Altman Z-Score | 8.53 |
| Piotroski F-Score | n/a |